Low-Dose Enzalutamide in Late-Elderly Patients (≥ 75 Years Old) Presenting With Metastatic Castration-Resistant Prostate Cancer
Vincent Vinh‐Hung, Gilles Natchagandé, Clarisse Joachim, Olena Gorobets, Moustapha Dramé, Stefanos Bougas, Edmund Folefac, Nam P. Nguyen, Claire F. Verschraegen, Ming Yin
Topics & Concepts
MedicineEnzalutamideProstate cancerUrologyBicalutamideInternal medicineAndrogen deprivation therapyOncologyCancerAndrogen receptorProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications